RecruitingNCT06287177
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy - CHOLINET (CHOLesterol Italian Inclisiran NETwork)
Sponsor
Federico II University
Enrollment
3,000 participants
Start Date
Nov 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life Italian population
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients under Inclisiran treatment
Exclusion Criteria2
- Age < 18 years o > 80 years
- Patients who refuse to participate and to sign informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGInclisiran
Injection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06287177
Related Trials
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
NCT0747770434 locations
Causes and Natural History of Dyslipidemias
NCT003537821 location
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
NCT0645177016 locations
A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins
NCT0763448410 locations
A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
NCT074045531 location